RadNet
RDNTRadNet is a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States.
Earnings
Next report
Nov 9, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
RadNet is a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates a vast network of imaging centers and provides a comprehensive suite of non-invasive diagnostic procedures to facilitate the diagnosis and treatment of diseases. Its value proposition is centered on a multi-modality strategy, regional market density, and the integration of advanced artificial intelligence to enhance clinical interpretation and operational efficiency.
RadNet is the largest operator of freestanding outpatient diagnostic imaging centers in the U.S. based on center count and revenue, leveraging significant scale and regional density.
FAQ
- What is RadNet's market cap?
- RadNet (RDNT) has a market capitalization of $6.1B and trades on NASDAQ.
- What is RadNet's revenue and profitability?
- RadNet generated $2.3B in trailing twelve-month revenue with a net loss of $21.1M, representing a net margin of -0.9%. Gross margin stands at 13.4%, with free cash flow of $80.0M. The latest reported period is Q2 2026.
- Who are RadNet's competitors?
- RadNet's key competitors include Lumexa Imaging Holdings, Inc. Common Stock, GE HealthCare Technologies Inc. Common Stock, QT Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does RadNet partner with?
- RadNet's notable partners include GE HealthCare, Hologic, Philips, and others.
- What subsidiaries does RadNet have?
- RadNet's subsidiaries include DeepHealth, Inc., eRad, Inc., Aidence Holding B.V., and others.
- Where is RadNet headquartered?
- RadNet is headquartered in United States of America and employs approximately 10,288 people. It has been publicly traded since 1994.
